# Symptomatic sinus bradycardia during the recovery phase of high-altitude pulmonary edema: a case report

**Authors:** Jiale Xie, Weiping Li, Jia Luan, Zhibiao Cai, Haijun Miao

PMC · DOI: 10.3389/fmed.2026.1754071 · Frontiers in Medicine · 2026-01-30

## TL;DR

A healthy man developed severe slow heart rate after recovering from high-altitude pulmonary edema, likely due to a rebound in vagal tone and steroid withdrawal.

## Contribution

Highlights a novel clinical observation linking HAPE recovery with symptomatic sinus bradycardia due to vagal rebound and steroid withdrawal.

## Key findings

- Symptomatic sinus bradycardia occurred during HAPE recovery with heart rate as low as 37 bpm.
- Intravenous potassium and fluid resuscitation resolved the bradycardia, restoring heart rate to 59 bpm.
- Rebound vagal tone and steroid withdrawal are suggested as contributing factors to the bradycardia.

## Abstract

This case report describes a 28-year-old healthy male who developed high-altitude pulmonary edema (HAPE) after a rapid ascent. While his condition improved with standard therapy (including corticosteroids, diuretics, and supplemental oxygen), he developed symptomatic sinus bradycardia (heart rate nadir: 37 bpm) 2 days after discontinuation of these medications. The bradycardia resolved with intravenous potassium supplementation and fluid resuscitation, and his heart rate recovered to 59 bpm. This case highlights that a rebound in vagal tone and steroid withdrawal may contribute to severe bradycardia during the HAPE recovery phase, warranting heightened clinical vigilance.

## Linked entities

- **Chemicals:** potassium (PubChem CID 813)
- **Diseases:** high-altitude pulmonary edema (MONDO:0021811)

## Full-text entities

- **Diseases:** altitude pulmonary edema (MESH:D011654), HAPE (MESH:C535833), sinus bradycardia (MESH:D012804), bradycardia (MESH:D001919), high (MESH:D008228)
- **Chemicals:** potassium (MESH:D011188), oxygen (MESH:D010100), steroid (MESH:D013256)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12901502/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12901502/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12901502/full.md

---
Source: https://tomesphere.com/paper/PMC12901502